Hannah Richards was part of the team that won the 2011 Biotechnology Young Entrepreneurs Scheme (YES). The team pitched a plan for a hypothetical business to a panel of investors and were ...
A new Diabetologist will be joining OCDEM at the beginning of February 2012. This will be Garry Tan, who many will remember as a Specialist Trainee and D.Phil student working with Fredrik Karpe. ...
Obesity is the single most important factor for the current increase in diabetes. There are different types of obesity: abdominal obesity is linked with diabetes and heart disease. Important genes have been identified. The Oxford Biobank will help us better understand physiology and function, the link between the molecule and the patient.
Dr Leanne Hodson has been awarded the prize of \u00a3250 for best presentation by a post-doctoral scientist at the Rank Prize Funds Symposium on 'Nutritional Biomarkers: Present Science and Future ...
We are pleased to announce that Nicola Beer (a final year DPhil student working under the supervision of Dr Anna Gloyn and Professor Patrik Rorsman at the Oxford Centre for Diabetes, Endocrinology, ...
Twelve new genes linked with type 2 diabetes have been found in a study into the differences in people's DNA and their risk of having the condition. The study was led by researchers at Oxford University and forms part of the Wellcome Trust case control consortium. Professor Mark McCarthy said \"Gradually we are piecing together clues about why some people get diabetes and other don't, with the potential for developing better treatments and preventing onset of diabetes in the future. For more information visit the BBC website.
We are please to announce that Dr Leanne Hodson of the OXLIP Group has been awarded the prestigious Association of Clinical Biochemists Professors' Prize for 2010. The award was made based on her ...
Two key treatments do not halt diabetes in people with early signs of the disease, a large study has found. Researchers said the results showed the only way to ensure future health in people at high risk of diabetes is exercise and a healthy diet. Trials in more than 9,000 people also found no reduction in future heart problems in people prescribed two drug treatments compared with dummy pills. In the trial, researchers in the US and UK looked at whether using a drug that lowers blood pressure or a drug which lowers blood sugar could be used to stop diabetes developing in high-risk patients. But the results, from patients in 40 countries, found no great difference in how many people went on to get diabetes when prescribed either drug compared with a dummy pill. Neither did the drugs prevent future heart attacks and strokes, which are dangerous complications of the condition.
\u2018It\u2019s hard to think back and remember how we worked then. We were scrabbling around in the dark,\u2019 says Professor Mark McCarthy of the Oxford Centre for Diabetes, Endocrinology and Metabolism [OCDEM], recalling how research on the genetic causes of disease had to be carried out before the human genome was sequenced.
An international research consortium has found 13 new genetic variants that influence blood glucose regulation, insulin resistance, and the function of insulin-secreting beta cells in populations of European descent. Five of the newly discovered variants increase the risk of developing type 2 diabetes, the most common form of diabetes.
![\"John](\"https://www.rdm.ox.ac.uk/news/international-diabetes-lecture-programme/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n